Sandbox:Roukoz: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 10: | Line 10: | ||
{{familytree | | | | | | | | | E02 | | | | | | | E02=Gender specific tests}} | {{familytree | | | | | | | | | E02 | | | | | | | E02=Gender specific tests}} | ||
{{familytree | | | | | | | |,|-|^|-|.| | | | | | }} | {{familytree | | | | | | | |,|-|^|-|.| | | | | | }} | ||
{{familytree | | | | | | |F01| | | |F02 | {{familytree | | | | | |boxstyle=text-align: left; |F01| | | |F02| | | | |F01='''Male'''<br> • PSA <br> • aFP <br> • BHCG|F02='''Female'''<br> • Mammography <br> • Ultrasound or pelvic CT}} | ||
{{familytree/end}} | {{familytree/end}} | ||
Revision as of 18:22, 10 October 2018
| Tumor of unknown primary origin | |||||||||||||||||||||||||||||||||||
| • Full medical history and physical exam • Basic blood and bichemical analysis • CT scan of chest, abdomen, and pelvis | |||||||||||||||||||||||||||||||||||
| Histopathologic examination | |||||||||||||||||||||||||||||||||||
| Squamous cell carcinoma | Adenocarcinoma and poorly differntiated carcinoma | Neuroendocrine carcinoma | |||||||||||||||||||||||||||||||||
| Gender specific tests | |||||||||||||||||||||||||||||||||||
| Male • PSA • aFP • BHCG | Female • Mammography • Ultrasound or pelvic CT | ||||||||||||||||||||||||||||||||||